Department of Radiology, Wakayama Medical University, 811-1 Kimiidera, Wakayama-shi, Wakayama, 641-8510, Japan.
Jpn J Radiol. 2013 Sep;31(9):585-92. doi: 10.1007/s11604-013-0223-7. Epub 2013 Jun 13.
To investigate the midterm results of abdominal aortic aneurysm repair (EVAR) and compare the endoleak (EL) and abdominal aortic aneurysm (AAA) prognoses between instruction-for-use (IFU) patients and non-IFU patients.
Of 124 patients (104 men, 20 women; mean age 76.2 years; age range 58-93 years) with AAA who underwent EVAR with the Zenith (68 patients) or Excluder device (56) and were analyzed, 86 were IFU and 38 non-IFU.
The mean absorbed dose of radiation exposure was 1907 mGy in the IFU group and 2283 mGy in the non-IFU group (p = 0.013). Thirty-five patients experienced EL: 8 (6.5 %) type I and 27 (21.8 %) type II. Type I ELs were observed in 3 patients in the IFU group (3.5 %) and 5 patients in the non-IFU group (13.2 %). Of the 14 patients with AAA diameter expansion of ≥ 5 mm, 6 (6/86, 7.0 %) belonged to the IFU group and 8 (8/38, 21.1 %) to the non-IFU group (p = 0.027).
The frequency of AAA expansion ≥ 5 mm was higher in non-IFU patients than in IFU patients. Therefore, careful follow-up is necessary for non-IFU patients rather than IFU patients.
研究腹主动脉瘤修复术(EVAR)的中期结果,并比较使用说明(IFU)患者和非 IFU 患者的内漏(EL)和腹主动脉瘤(AAA)预后。
对 124 例接受 EVAR 的 AAA 患者(104 例男性,20 例女性;平均年龄 76.2 岁;年龄 58-93 岁)进行分析,其中 Zenith (68 例)或 Excluder 装置(56 例),86 例为 IFU,38 例为非 IFU。
IFU 组的平均吸收辐射剂量为 1907 mGy,非 IFU 组为 2283 mGy(p = 0.013)。35 例患者出现 EL:8 例(6.5%)为 I 型,27 例(21.8%)为 II 型。IFU 组有 3 例(3.5%)和非 IFU 组有 5 例(13.2%)患者出现 I 型 EL。在 14 例 AAA 直径扩张≥5mm 的患者中,6 例(6/86,7.0%)属于 IFU 组,8 例(8/38,21.1%)属于非 IFU 组(p = 0.027)。
非 IFU 患者的 AAA 扩张≥5mm 的频率高于 IFU 患者。因此,非 IFU 患者需要更密切的随访,而非 IFU 患者。